Stonehage Fleming Financial Services Holdings Ltd

Position in NVAX — Novavax Inc

CIK 1786379 ST. HELIER, Y9

Position in NVAX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$152,258

+$26,561 QoQ

Shares Held

18,705

0.0% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Stonehage Fleming Financial Services Holdings Ltd holds $460,884 across 6 Biotechnology names. NVAX ranks #2 (33.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SRPT	Sarepta Therapeutics, Inc.	9,614	$209,200
2	NVAX	Novavax Inc This page	18,705	$152,258
3	ATAI	AtaiBeckley Inc.	19,080	$67,543
4	CALC	CalciMedica, Inc.	53,703	$28,999
5	BNTX	BioNTech SE	30	$2,666
6	PBM	Psyence Biomedical Ltd.	89	$218

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$152,258	18,705	0.0%	Shares	Other	2026-05-13
2025-12-31	$125,697	18,705	—	Shares	Other	2026-01-13
No filing history on record for this holder in this stock.